Pharmacokinetic and pharmacodynamic interactions of aminophylline and topiramate in the mouse maximal electroshock-induced seizure model

European Journal of Pharmacology

Volumn 562, Issue 1-2, 2007, Pages 53-59

  Luszczki, Jarogniew J ^a   Jankiewicz, Katarzyna ^a   Jankiewicz, Marek ^a   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Aminophylline; Chimney test; Maximal electroshock; Pharmacodynamic interaction; Pharmacokinetic interaction; Topiramate

Indexed keywords

AMINOPHYLLINE; SODIUM CHLORIDE; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG POTENTIATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

AMINOPHYLLINE; ANIMALS; ANTICONVULSANTS; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROSHOCK; FRUCTOSE; MALE; MICE; MOTOR ACTIVITY; SEIZURES;

EID: 33947545106     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.038     Document Type: Article

References (52)

1. Angehagen M., Ben-Menachem E., Shank R., Ronnback L., and Hansson E. Topiramate modulation of kainate-induced calcium currents is inversely related to channel phosphorylation level. J. Neurochem. 88 (2004) 320-325
2. Ault B., Olney M.A., Joyner J.L., Boyer C.E., Notrica M.A., Soroko F.E., and Wang C.M. Pro-convulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy. Brain Res. 426 (1987) 93-102
3. Boissier J.R., Tardy J., and Diverres J.C. Une nouvelle méthode simple pour explorer l'action tranquilisante: le test de la cheminée. Med. Exp. (Basel) 3 (1960) 81-84
4. Bonilha L., and Li L.M. Heavy coffee drinking and epilepsy. Seizure 13 (2004) 284-285
5. Borowicz K.K., Luszczki J.J., and Czuczwar S.J. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice. Epilepsia 45 (2004) 1176-1183
6. Brodie M.J., and Schachter S.C. Fast Facts. Epilepsy. Second ed. (2001), Health Press, Oxford
7. Cadart M., Marchand S., Pariat C., Bouquet S., and Couet W. Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats. Pharm. Res. 19 (2002) 209-214
8. Chu N.S. Caffeine- and aminophylline-induced seizures. Epilepsia 22 (1981) 85-94
9. Corradetti R., Lo Conte G., Moroni F., Passani M.B., and Pepeu G. Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol. 104 (1984) 19-26
10. Czuczwar S.J., and Kleinrok Z. Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients. Pharmacol. Res. 22 (1990) 661-665
11. Czuczwar S.J., Turski W.A., Ikonomidou C., and Turski L. Aminophylline and CGS 8216 reverse the protective action of diazepam against electroconvulsions in mice. Epilepsia 26 (1985) 693-696
12. Czuczwar S.J., Ikonomidou C., Kleinrok Z., Turski L., and Turski W. Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 27 (1986) 204-208
13. Czuczwar S.J., Jäckel R., and Löscher W. Effects of aminophylline and enprofylline on the protective activity of phenobarbital against amygdala-kindled seizures in rats. Epilepsy Res. 1 (1987) 234-238
14. Czuczwar S.J., Janusz W., Wamil A., and Kleinrok Z. Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur. J. Pharmacol. 144 (1987) 309-315
15. Czuczwar S.J., Kleinrok Z., Turski L., and Turski W.A. Effect of aminophylline and enprofylline on the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 28 (1987) 383-386
16. Czuczwar S.J., Janusz W., Szczepanik B., Wamil A., and Kleinrok Z. Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci. Res. 6 (1989) 470-474
17. Dodgson S.J., Shank R.P., and Maryanoff B.E. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41 Suppl 1 (2000) S35-S39
18. French J.A., Kanner A.M., Bautista J., Abou-Khalil B., Browne T., Harden C.L., Theodore W.H., Bazil C., Stern J., Schachter S.C., Bergen D., Hirtz D., Montouris G.D., Nespeca M., Gidal B., Marks W.J., Turk W.R., Fischer J.H., Bourgeois B., Wilner A., Faught R.E., Sachdeo R.C., Beydoun A., Glauser T.A., American Academy of Neurology Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology Quality Standards Subcommittee, American Epilepsy Society Therapeutics and Technology Assessment Subcommittee, and American Epilepsy Society Quality Standards Subcommittee. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 45 (2004) 410-423 (Erratum in: 2004. Epilepsia 45, 1299)
19. Gasior M., Swiader M., Przybylko M., Borowicz K., Turski W.A., Kleinrok Z., and Czuczwar S.J. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice. Eur. J. Pharmacol. 352 (1998) 207-214
20. Gibbs J.W., Sombati S., DeLorenzo R.J., and Coulter D.A. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 Suppl 1 (2000) S10-S16
21. Gryder D.S., and Rogawski M.A. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J. Neurosci. 23 (2003) 7069-7074
22. Gulati K., Ray A., Pal G., and Vijayan V.K. Possible role of free radicals in theophylline-induced seizures in mice. Pharmacol. Biochem. Behav. 82 (2005) 241-245
23. Herrero A.I., Del Olmo N., Gonzalez-Escalada J.R., and Solis J.M. Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance. Neuropharmacology 42 (2002) 210-220
24. Hornfeldt C.S., and Larson A.A. Adenosine receptors are not involved in theophylline-induced seizures. J. Toxicol., Clin. Toxicol. 32 (1994) 257-265
25. Jensen M.H., Jorgensen S., Nielsen H., Sanchez R., and Andersen P.K. Is theophylline-induced seizures in man caused by inhibition of cerebral 5′-nucleotidase activity?. Acta Pharm. Toxicol. 55 (1984) 331-334
26. Kaufman K.R., and Sachdeo R.C. Caffeinated beverages and decreased seizure control. Seizure 12 (2003) 519-521
27. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96 (1949) 99-113
28. Lohmann S.M., and Miech R.P. Theophylline metabolism by the rat liver microsomal system. J. Pharmacol. Exp. Ther. 196 (1976) 213-225
29. Löscher W., and Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2 (1988) 145-181
30. Löscher W., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 8 (1991) 79-94
31. Luszczki J.J., and Czuczwar S.J. Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis. Epilepsia 45 (2004) 895-907
32. Luszczki J.J., and Czuczwar S.J. How significant is the difference between drug doses influencing the threshold for electroconvulsions?. Pharmacol. Reprod. 57 (2005) 782-786
33. Luszczki J.J., and Czuczwar S.J. Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model. Naunyn-Schmiedeberg's Arch. Pharmacol. 372 (2005) 41-54
34. Luszczki J.J., Borowicz K.K., Swiader M., and Czuczwar S.J. Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia 44 (2003) 489-499
35. Luszczki J.J., Swiader M., Czuczwar M., Kis J., and Czuczwar S.J. Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol. Biochem. Behav. 75 (2003) 319-327
36. Luszczki J.J., Ratnaraj N., Patsalos P.N., and Czuczwar S.J. Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Epilepsy Behav. 7 (2005) 639-651
37. Luszczki J.J., Mohamed M., and Czuczwar S.J. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice. Eur. J. Pharmacol. 531 (2006) 66-73
38. Luszczki J.J., Ratnaraj N., Patsalos P.N., and Czuczwar S.J. Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn-Schmiedeberg's Arch. Pharmacol. 373 (2006) 169-181
39. Luszczki J.J., Ratnaraj N., Patsalos P.N., and Czuczwar S.J. Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis. Epilepsia 47 (2006) 1841-1854
40. Nakada T., Kwee I.L., Lerner A.M., and Remler M.P. Theophylline-induced seizures: clinical and pathophysiologic aspects. West. J. Med. 138 (1983) 371-374
41. Neering I.R., and McBurney R.N. Role for microsomal Ca storage in mammalian neurones?. Nature 309 (1984) 158-160
42. Persson C.G., Andersson K.E., and Kjellin G. Effects of enprofylline and theophylline may show the role of adenosine. Life Sci. 38 (1986) 1057-1072
43. Shank R.P., Gardocki I.F., Streeter A.J., and Maryanoff B.E. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanisms of action. Epilepsia 41 Suppl. 1 (2000) S3-S9
44. + current fractions by the new anticonvulsant topiramate. J. Pharmacol. Exp. Ther. 288 (1999) 960-968
45. Urbanska E.M., Drelewska E., Borowicz K.K., Blaszczak P., Kleinrok Z., and Czuczwar S.J. NG-nitro-l-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice. J. Neural Transm. 103 (1996) 1145-1152
46. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41 Suppl 1 (2000) S17-S20
47. Wlaz P., Rolinski Z., Kleinrok Z., and Czuczwar S.J. Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline. J. Neural Transm.: Gen. Sect. 89 (1992) 41-48
48. Wlaz P., Rolinski Z., Kleinrok Z., and Czuczwar S.J. Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice. Epilepsia 34 (1993) 385-389
49. Wlaz P., Rolinski Z., Kleinrok Z., and Czuczwar S.J. Influence of chronic aminophylline on antielectroshock activity of diazepam and aminophylline-induced convulsions in mice. Pharmacol. Biochem. Behav. 49 (1994) 609-613
50. Yarnell P.R., and Chu N.S. Focal seizures and aminophylline. Neurology 25 (1975) 819-822
51. Zhang X., Velumian A.A., Jones O.T., and Carlen P.L. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 41 Suppl 1 (2000) S52-S60
52. Zwillich C.W., Sutton F.D., Neff T.A., Cohn W.M., Matthay R.A., and Weinberger M.M. Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann. Intern. Med. 82 (1975) 784-787